You are here

  • Home
  • Archive
  • Volume 16, Issue 6
  • In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol

https://doi.org/10.1136/ebm1411

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests TK has received honoraria from AstraZeneca Canada, Nycomed Canada and Merck Frosst Canada.